Status:
COMPLETED
A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this research study is to determine the effectiveness of 2 target doses of R228060 in comparison with placebo during 6 weeks of treatment in moderately to severely depressed adult subje...
Eligibility Criteria
Inclusion
- Generally healthy adults on the basis of a physical examination, medical history, ECG and laboratory work-up.
- Subject needs to meet criteria for diagnosis of moderate or severe major depression as defined by the protocol.
- The subject also needs to be an outpatient to participate in this study.
Exclusion
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
May 1 2004
Estimated Enrollment :
488 Patients enrolled
Trial Details
Trial ID
NCT00073203
End Date
May 1 2004
Last Update
August 28 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
JJ PRD Research Center
Titusville, New Jersey, United States, 08560